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Abstract
Objective—To assess the role of point-of-care (PoC) assessment of C-reactive protein (CRP) and 
white blood cell (WBC) count to identify bacterial illness in Tanzanian children with non-severe 
non-malarial fever.
Methods—From the outpatient department of a district hospital in Tanzania, 428 patients 
between 3 months and 5 years of age who presented with fever and a negative malaria test were 
enrolled. All had a physical examination and bacterial cultures from blood and urine. 
Haemoglobin, CRP and WBC were measured by PoC devices.
Results—Positive blood cultures were detected in 6/428 (1.4%) children and urine cultures were 
positive in 24/401 (6.0%). Mean WBC was similar in children with or without bacterial illness 
(14.0 × 109, 95% CI 12.0–16.0 × 109 vs. 12.0 × 109, 95% CI 11.4–12.7 × 109), while mean CRP 
was higher in children with bacterial illness (41.0 mg/l, 95% CI 28.3–53.6 vs. 23.8 mg/l, 95% CI 
17.8–27.8). In ROC analysis, the optimum cut-off value for CRP to identify bacterial illness was 
19 mg/l but with an area under the curve of only 0.62. Negative predictive values exceeded 80%, 
while positive predictive values were under 40%.
Conclusion—WBC and CRP levels had limited value in identifying children with bacterial 
infections. The positive predictive values for both tests were too low to be used as single tools for 
treatment decisions.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, 
distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
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Introduction
Childhood febrile illnesses in resource-poor settings are often treated presumptively with 
antibiotics and/or antimalarials due to the lack of diagnostic tools to differentiate between 
aetiologies. Since 2010, WHO recommend parasitological testing to guide antimalarial drug 
use wherever possible and the subsequent availability of malaria rapid diagnostic tests 
(RDTs) provides an opportunity for improved management of paediatric febrile illness [1, 
2]. However, inappropriate treatment of malaria-negative patients continues [3]. Where 
increased testing for malaria has been introduced, antibiotic prescribing is poorly targeted 
and often increased [4–6], in spite of evidence that many of these infections are viral [7–9].
Levels of C-reactive protein (CRP) and white blood cells (WBC) can be assessed by point-
of-care (PoC) tests that may differentiate between bacterial and viral illnesses, but results 
remain inconclusive [10–14]. Despite these disparities in results, WBC and CRP are 
commonly used in high-income settings and may be valuable to reduce numbers of blood 
cultures in hospitalised children or limit antibiotic use in outpatients [15, 16]. To our 
knowledge, the potential for CRP and WBC to identify bacterial infections in non-severe 
paediatric fevers has not been clarified in sub-Saharan Africa.
Methods
Study area
Data collection took place at St Augustine’s Hospital (formally Teule Hospital), Muheza 
District, Tanzania, from July 2011 until November 2012. St Augustine’s Hospital primarily 
covers a rural population where malaria transmission is perennial with increased 
transmission during the two rainy seasons. There has been a considerable decline in the 
prevalence of Plasmodium falciparum in recent years [17]. Patient residency in one of the 85 
villages from which there had been more than 10 paediatric admissions to St Augustine’s 
Hospital in 2006 was used to define the study area.
Procedures
Patients were recruited at the hospital’s Reproductive and Child Health clinic. Patients 
between 3 months and 5 years of age were consecutively recruited to enter a first and second 
screening. The first screening assessed children for presence of fever on that day or the day 
before, residency in the study area and absence of life-threatening illness, as defined in the 
Integrated Management of Childhood Illness (IMCI) algorithm [18].
In the second screening, patients were excluded if they suffered from an obvious soft tissue 
infection, if they presented with a chronic condition except HIV infection – which was only 
recorded if reported by the patient’s guardian – and if the patient had already been enrolled 
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in the same study within the previous month. A negative rapid test for P. falciparum 
(Paracheck™; Orchid Biomedical, Mumbai) was required to enter the study.
If a child was eligible for enrolment, the study information was read to the patient’s 
guardian, and after informed consent had been obtained, a clinical history and examination 
were recorded by a study clinical officer using the IMCI algorithm [18]. Enrolled patients 
were asked to return to the hospital for scheduled follow-up visits after 1 and 2 weeks to 
collect data on symptom progression as reported in a related publication [9].
Laboratory procedures
A maximum of 10 ml of blood was drawn from all enrolled patients through sterile 
venepuncture using a butterfly and syringe. At least 3–6 ml of blood was aseptically 
inoculated into a BactALERT (BioMerieux, France) paediatric FAN aerobic culture bottle. 
All cultures with growth of a suspected or verified pathogen were immediately reported back 
to the clinicians to allow for treatment adjustments of affected patients. Detailed information 
on blood culture procedures and results is reported in a related publication [9].
Remaining venous blood was used for PoC measurement of haemoglobin (HemoCue™, 
Ängelholm, Sweden), CRP (Afinion AS100 Analyzer™; Axis-Shield, Oslo, Norway) and 
white blood cell count (HemoCue™, Ängelholm, Sweden). CRP results less than 5 mg/l 
were reported by the machine as <5 mg/l, while results higher than 200 mg/l were reported 
as >200 mg/l. CRP results above 100 mg/l were repeated to confirm results but did not have 
any impact on management decisions.
Urine samples were obtained by clean catch collection at enrolment. Careful instructions for 
cleaning before sample collection were given to all caretakers to avoid skin pathogen 
contamination of urine samples. Urine was collected in sterile bottles and a Multistix 
dipstick was performed immediately upon receiving the urine. If nitrate- or leucocyte-
positive, the urine was sent for bacterial culture within 1 h of collection. A growth of 105 
colony-forming units (cfu) per ml was considered significant bacteriuria. If a urine culture 
resulted in two or more colony types at greater than 105/ml, it was reported as contaminated 
and a repeat specimen requested. Bacillus species and coagulase-negative organisms other 
than Staphylococcus saprophyticus were reported as contaminants and not further identified.
Data management and analysis
For the analysis of relations between CRP/WBC levels and bacterial infections, we defined 
potential bacterial infections as either a positive urine or blood culture or symptoms 
suggestive of IMCI pneumonia as defined in the IMCI algorithm during the study period, for 
example cough or difficult breathing with a respiratory rate of >40 breaths/min for children 
older than 1 year and >50 breaths/min for children below 1 year of age [18].
Data were manually double-entered in MS Access and analysed using Dell Statistica version 
13 and Stata 12 software. Proportions with confidence intervals were calculated for 
prevalence of clinical characteristics. Wilcoxon rank-sum test was used to compare 
continuous variables between groups, and Mann–Whitney U-test with receiver operator 
characteristic was used to identify cut-off values for CRP/WBC to predict bacterial illness.
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Ethics
Written informed consent to participate was obtained from the parent or legal guardian of 
each child in the study. The Ethical Review Boards of the National Institute for Medical 
Research in Tanzania approved the study including the consent procedures.
Results
A total of 428 patients between 3 months and 5 years of age were enrolled in the study. 
Figure 1 shows a flow chart of screening procedures. The most common symptom presented 
at enrolment was cough, reported in 279/428 (65.2%, 95% CI 60.7–69.7) children, while 
60/428 (14.0%, 95% CI 10.7–17.3) children met the IMCI criteria for non-severe 
pneumonia, that is cough or difficult breathing with an increased respiratory rate for age. A 
pathogen detected by blood culture was identified in 6/428 (1.4%, 95% CI 0.3–2.5). A total 
of 401/428 (93.7%, 95% CI 91.4–96.0) children provided a urine sample. Of these, 24/401 
(6.0%, 95% CI 3.7–8.3) had a positive urine culture. Details of the bacteria identified in 
cultures are presented in Table S1. Table 1 shows additional background details on all 
enrolled by illness classification.
Table 2 provides information on mean and median values of haemoglobin, CRP and WBC 
depending on illness classification. WBC did not differ significantly between children with 
IMCI pneumonia/positive urine or blood culture (mean 14.0 × 109, 95% CI 12.0–16.0 × 109, 
median 13.5 × 109) and those without signs of bacterial infection (mean 12.0 × 109, 95% CI 
11.4–12.7 × 109, median 11.5 × 109). CRP was significantly higher in children with IMCI 
pneumonia/positive urine or blood culture (mean 41.0 mg/l, 95% CI 28.3–53.6 median 16 
mg/l) vs. children without any signs of bacterial infection (mean 23.8 mg/l, 95% CI 17.8–
27.8, median 7 mg/l).
C-reactive protein and bacterial infection
Overall, 256/428 (59.8%, 95% CI 55.2–64.5) children had a CRP value of less than 20 mg/l. 
Of these, 215/256 (84.0%, 95% CI 79.5–88.5) were children with no signs of bacterial 
infection, that is no positive blood or urine culture and no IMCI pneumonia. Applying a cut-
off value of CRP at 20 mg/l, the negative likelihood ratio for either a positive blood or urine 
culture or IMCI pneumonia was 0.71 (95% CI 0.57–0.87). The negative likelihood ratio for a 
positive urine culture with a CRP below 20 was 0.55 (95% CI 0.33–0.90) and for a positive 
blood culture 0.64 (95% CI 0.24–1.70). Nevertheless, nine children with a positive urine 
culture had a CRP below 20 mg/l and two children with a positive blood culture had a CRP 
below 5 mg/l. None of these presented with any severity signs as defined in the IMCI 
algorithm, and the fever had reportedly been present for at least two days.
Of all enrolled, 33/428 (7.7%, 95% CI 5.2–10.2) had a CRP level above 80 mg/l. Twelve of 
these 33 (36.7%, 95% CI 20.3–53.1) had some sign of bacterial infection (positive urine or 
blood culture or IMCI pneumonia). Repeat CRP tests were carried out in 29 patients, and 12 
(41.4%) of these showed a similar result of >200 mg/l in both tests.
The ROC analysis suggested a cut-off for CRP of 19 mg/l to differentiate between children 
with and without signs of bacterial infection, for example positive urine/blood culture or 
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IMCI pneumonia, but the area under the curve (AUC) was low at only 0.62. Similar cut-offs 
and AUC values were yielded in separate ROC analysis for blood cultures, urine cultures 
and IMCI pneumonias, respectively (Figure 2).
White blood cell density and bacterial infection
Seventeen patients had a WBC of above 20 × 109/l. Most of these (13/17, 76.5%, 95% CI 
56.3–96.7) had no signs of bacterial infection. There were no tendencies of higher WBC 
counts in children with positive urine or blood culture nor among children with IMCI 
pneumonia, and the AUC in ROC analysis was low at 0.52 (Figure 3).
Based on the cut-off values for CRP and WBC identified in the ROC analysis, sensitivity, 
specificity and positive and negative predictive values (NPV) were calculated (Table 3). For 
both CRP and WBC, NPV reached above 80% – mainly explained by the low prevalence of 
positive cultures – while positive predictive values were all less than 35.9%.
Discussion
Point-of-care bring a number of advantages that are particularly relevant to resource-poor 
countries such as their simplicity and independence from distant laboratories or complex 
quality control systems. However, PoC tests come at a cost, both financial and in health 
worker time, and their use must be justified by evidence. In this study, we found that the 
measurement of white blood cells and CRP did not facilitate diagnosis of bacterial illness in 
children with malaria-negative fever in Tanzania. As a single indicator of bacterial infection, 
both WBC and CRP did not provide sufficient accuracy to justify their use in assessing 
children with non-severe febrile illness.
Assessment of white blood cells failed to show any significant difference between children 
with and without suspected bacterial infections. The use of white blood cell differential 
count has a long history of use as a diagnostic marker of bacterial illness but in recent 
studies has shown poor specificity and sensitivity in a review of potential biomarkers to 
identify serious bacterial illness [19]. This study confirms the limited diagnostic use of WBC 
testing in paediatric fevers in resource-poor settings.
In comparison, CRP values were generally higher among children with suspected or 
confirmed bacterial illness than among children without any signs of bacterial illness. The 
cut-offs in ROC analysis were around 20 mg/l for IMCI pneumonia as well as for confirmed 
positive urine or blood cultures, but as in other studies, the AUC values were too poor for the 
cut-off value to be trusted [14, 20]. Notably, the suggested cut-off and AUC values were 
similar for IMCI pneumonia and confirmed positive blood cultures. This is despite the fact 
that the IMCI algorithm for pneumonia used in 2011/12 is known to over-diagnose 
pneumonia. In other studies, the use of CRP assessment has proven useful to predict 
radiologically confirmed pneumonia, and even to differentiate viral from bacterial causes [8, 
12, 21, 22]. Results from these previous studies have suggested higher cut-off values of CRP 
in pneumonia than the one in this study, the value perhaps being lower due to the incomplete 
availability of X-rays.
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The current IMCI algorithm does not include any suggestions on how to diagnose urinary 
tract infections although these infections contribute to more than 5% of paediatric fevers [9]. 
Urine dipsticks have been suggested as part of a refined algorithm to assess paediatric fevers 
in low-resource settings, but sampling of urine is time-consuming and samples are easily 
contaminated [23]. Considering the relatively high NPV of CRP for urinary tract infections, 
a combination of urine dipstick and CRP assessment may be useful to improve diagnostic 
accuracy of paediatric urinary tract infections and in particular contribute to the 
identification of children with upper urinary tract infections and risks of renal scarring [24].
The suggested cut-off in ROC analysis for CRP levels to consider bacterial illness was 19 
mg/l. This is similar to the proposed cut-off value of 20 mg/l to rule out severe bacterial 
infection in a systematic review of paediatric fevers [25]. Still, some children who were 
admitted had a normal CRP level, for example below 5 mg/l, despite being sick enough to 
require admission. While none of these children had features specific to bacterial disease and 
thus may have suffered viral infections, it highlights the importance of not relying on a 
single marker in the assessment of a sick child but rather combines different diagnostic tools 
to decide on how the illness should be managed. The low prevalence of positive blood 
cultures in outpatients will inevitably result in very low positive predictive values of 
anything other than a very accurate test and makes it unlikely that any single symptom or 
biomarker alone can guide treatment when assessing a febrile child.
Study limitations
We excluded patients with a positive malaria RDT in this study as earlier studies have shown 
the inability of CRP/WBC to differentiate between malaria and bacterial infections despite 
tendencies of higher values in bacterial infections [26]. Urine cultures were only performed 
on children with a dipstick positive for leucocytes and/or nitrate, and we may thus have 
missed some urinary tract infections without pathologic results on urine dipsticks. 
Furthermore, as RDTs may remain positive after the malaria illness has resolved, there is a 
risk that some patients with a positive RDT also suffered bacterial/viral illness and were 
incorrectly excluded. The use of IMCI pneumonia as a proxy for bacterial pneumonia 
diagnosis is known to overestimate pneumonia but was used as high-quality X-rays were 
only available for 50% of included children. The rather low percentage of IMCI pneumonias 
compared to other studies may be partly due to an intense training of research staff to count 
respiratory rate properly but may also be influenced by the inclusion criteria requiring fever 
today or yesterday to enter the study, possibly decreasing the overall severity of illness in the 
group. As serological tests were not carried out, some patients may have suffered from 
zoonoses in which CRP/WBC levels remain unknown [27].
Furthermore, the normal distribution of CRP may differ between different areas and also 
seem to be affected by malaria endemicity as well as genetic factors that may limit 
generalisability and call for local cut-off recommendations [28, 29].
The Afinion CRP analyser can only work in a temperature range between 15 and 32°C, 
which obviously constitutes a limitation for PoC analysis of CRP in tropical settings in 
general.
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Conclusions
We conclude that assessment of WBC count had a limited value in the identification of 
children with bacterial infections in non-malarial fevers presenting to an outpatient 
department. Both CRP and WBC measurements resulted in positive predictive values that 
were too low to be used as a single tool for treatment decisions.
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Figure 1. 
Study flow chart. As two children with Integrated Management of Childhood Illness (IMCI) 
pneumonia also had a positive urine culture and one child with IMCI pneumonia had a 
positive blood culture, the sum of all diagnoses is 431.
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Figure 2. 
ROC curves for C-reactive protein (mg/l) in relation to (a) positive urine culture, (b) positive 
blood culture, (c) IMCI pneumonia and (d) all suspected bacterial infections.
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Figure 3. 
ROC curve for white blood cells (×109) in relation to all suspected bacterial infections.
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Table 1
Clinical characteristics of 428 children 3–59 months with malaria-negative fever
No IMCI criteria of 
bacterial infection (N = 
341)
IMCI pneumonia* (N 
= 60)
Urine culture positive 
(N = 24)
Blood culture positive (N = 
6)
Age <12 months n (%, 
95% CI) N = 174
126 (72.4, 65.8–79.0)  31 (17.8, 12.1–23.5)   16 (9.2, 4.9–13.5)    4 (2.3, 0.1–4.6)
Age 1–5 years n (%, 
95% CI) N = 254
215 (84.6, 80.2–89.1)  29 (11.4, 7.5–15.3)     8 (3.1, 1.0–5.0)    2 (0.8, −0.3 to 1.9)
Females n (%, 95% CI) 184 (54.0, 48.7–59.2)  24 (40.0, 27.6–52.4)   12 (50.0, 30.0–70.0)    5 (83.3, 53.5–113.1)
Temp > 37.5 n (%, 95% 
CI)
142 (41.6, 36.4–46.8)  44 (73.3, 62.1–84.5)     8 (33.3, 14.5–52.2)    4 (66.7, 28.9–104.4)
Days with fever mean 
(median)
 3.3 (3) 2.9 (3)  3.1 (3) 5.5 (5.5)
Admitted n (%, 95% CI)     8 (2.3, 0.7–3.9)  17 (28.3, 16.9–39.7)     0    1 (16.7, −13.1 to 46.5)
IMCI, Integrated Management of Childhood Illness.
*As two children with IMCI pneumonia also had a positive urine culture and one child with IMCI pneumonia had a positive blood culture, the sum 
of all diagnoses is 431.
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Table 2
Haemoglobin, C-reactive protein and white blood cell median and mean values by illness classification
No IMCI criteria of 
bacterial infection (N = 
341)
IMCI pneumonia (N 
= 60)*
Urine culture positive 
(N = 24)
Blood culture positive 
(N = 6)
Haemoglobin g/dl mean 
(median)
11.1 (11.3) 10.4 (10.6) 10.5 (10.7) 10.6 (10.9)
CRP mg/l mean (median) 23.8 (7) 40.1 (13) 45.0 (24) 29.5 (22)
WBC × 109/l mean (median) 12.0 (11.5) 13.8 (13.5) 14.7 (13.4)   9.2 (8.1)
IMCI, Integrated Management of Childhood Illness.
*As two children with IMCI pneumonia also had a positive urine culture and one child with IMCI pneumonia had a positive blood culture, the sum 
of all diagnoses is 431.
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Table 3
Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CRP 19 mg/l 
and WBC <5.0* or >17.4 × 109 to predict paediatric infections
Variable Cut-off point Illness cause
Sensitivity (%, 
95% CI)
Specificity (%, 
95% CI) PPV (%, 95% CI) NPV (%, 95% CI)
CRP 19 mg/l All 44.6 (33.2–56.6) 78.5 (73.0–83.1) 35.9 (26.3–46.6) 84.0 (78.8–88.1)
UTI 57.1 (34.4–77.4) 78.4 (72.6–83.1) 17.9 (9.9–29.6) 95.7 (91.7–97.9)
Bacteraemia 50.0 (9.2–90.8) 78.5 (73.0–83.1)   3.3 (0.6–12.1) 99.1 (96.4–99.8)
IMCI pneumonia 37.5 (24.3–52.7) 78.5 (73.0–83.1) 23.4 (14.8–34.7) 87.8 (82.8–91.5)
WBC <5.0 or >17.4 × 109 All 27.8 (14.8–45.4) 83.7 (77.9–88.3) 22.7 (12.0–38.2) 87.1 (81.4–91.2)
UTI 40.0 (13.7–72.6) 82.9 (77.3–87.4)   9.1 (3.0–22.6) 97.0 (93.3–98.8)
Bacteraemia 33.3 (1.8–87.5) 83.7 (77.9–88.3)   2.9 (0.1–16.6) 98.9 (95.5–99.8)
IMCI pneumonia 23.8 (9.1–47.5) 83.7 (77.9–88.3) 12.8 (4.8–28.2) 91.6 (86.5–95.0)
IMCI, Integrated Management of Childhood Illness.
*As some bacterial infections present with a low WBC, we also used a lower cut-off limit for WBC.
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